Effective July 1, 2026, Nestlé Health Science and Nestlé Nutrition have merged. As we make the transition, you will see some changes to this website.

Choose language:

Open Menu

Rice TW et al. Dietary Management of Blood Glucose in Medical Critically Ill Overweight and Obese Patients: An Open-Label Randomized Trial. JPEN. 2018; 43(4): 471-480.

Dietary Management of Blood Glucose in Medical Critically Ill Overweight and Obese Patients: An Open-Label Randomized Trial.

Use of a very high protein, enzymatically hydrolyzed, 100% whey, low carbohydrate enteral nutrition formula was related to decreased hyperglycemic events and requirement for insulin administration in critically ill overweight/ obese patients in an ICU.

This site is intended only for Canadian healthcare professionals. The products discussed in this site may have different product labeling in different countries.
In the event of a discrepancy between website information and product packaging, please refer to product packaging.
The information provided is for educational purposes only.

All trademarks are owned by Société des Produits Nestlé S.A., Vevey, Switzerland and used under license. ©2026 Nestlé.